Skip to content

A prospective, single-group, open-label clinical trial to evaluate the efficacy and safety of hemodialysis equipment for blood purification treatment in patients with chronic renal failure

A prospective, single-group, open-label clinical trial to evaluate the efficacy and safety of hemodialysis equipment for blood purification treatment in patients with chronic renal failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121656
Enrollment
Unknown
Registered
2026-04-01
Start date
2025-12-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney failure

Interventions

Experimental group:Blood purification treatment using EXH 8100/EXH 8200 equipment

Sponsors

Guangzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, body weight >= 40 kg, and gender not restricted; 2. Planned to receive any one of the following blood purification therapies: Hemodialysis; Hemofiltration; Hemodiafiltration; Isolated ultrafiltration. 3. Voluntarily participate in this clinical trial and have signed a written informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients with concurrent systemic infection, malignant tumor, or severe diseases of the heart, liver, or lungs. 2. Patients unable to cooperate with treatment, such as those with mental illnesses. 3. Pregnant or lactating women. 4. Have participated in other clinical trials within 30 days prior to enrollment. 5. Other circumstances that the investigator deems inappropriate for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Pass rate of blood dialysis equipment performance;Ease of use and convenience of hemodialysis equipment;Creatinine decline rate;Urea decline rate;

Secondary

MeasureTime frame
Changes in routine blood tests (RBC, WBC, PLT, Hb, HCT);Changes in the six ions (K, Na, Cl, Ca, Mg, P);Changes in blood gas analysis (HCO3-);

Countries

China

Contacts

Public ContactZhong Xiaoshi

Guangzhou Red Cross Hospital

2453075701@qq.com+86 137 2511 0102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026